Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Prostatic Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Glioblastoma 6Rectal Neoplasms 5Oropharyngeal Neoplasms 5Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Lung Neoplasms 4Burkitt Lymphoma 4Astrocytoma 4Urinary Bladder Neoplasms 3Mouth Neoplasms 3Glioma 3Carcinoma, Squamous Cell 3Adenocarcinoma of Lung 3Rhabdomyosarcoma 2Pancreatic Neoplasms 2Mesothelioma, Malignant 2Lymphoma, Follicular 2Laryngeal Neoplasms 2Hodgkin Disease 2Esophageal Neoplasms 2Carcinoma 2Breast Carcinoma In Situ 2Adenocarcinoma, Bronchiolo-Alveolar 2Wilms Tumor 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Skin Neoplasms 1

Interventions

trastuzumab deruxtecan 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation 1Platinum 1Congresses as Topic 1Cisplatin 1Bupropion 1Brachytherapy 1Axitinib 13-aminopyridine-2-carboxaldehyde thiosemicarbazone 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Vaginal Neoplasms × Radiotherapy × 30 days × Clear all
NCT02466971 2026-05-29

Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

National Cancer Institute (NCI)

Phase 3 Active not recruiting
450 enrolled 11 charts
Gynecologic

Uterine Cervical Neoplasms, Vaginal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡